Clinical trial
Severe Malaria and Anti-malarial Drug Resistance in Cambodia
NCT00341003 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00341003 |
|---|---|
| Title | Severe Malaria and Anti-malarial Drug Resistance in Cambodia |
| Official title | Multidisciplinary Studies of Severe Malaria and Antimalarial Drug Resistance in Cambodia |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Severe Malaria, Malaria, Antimalarial Drug Resistance |
| Enrollment | 2,090 |
| Start date | Jul 22, 2005 |
| Completion | Jan 14, 2011 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | Cambodia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: